Fmoc-Val-Cit-PAB - CAS 159858-22-7 Catalog number: BADC-00364

Fmoc-Val-Cit-PAB, a chemical linker at the forefront of drug delivery and targeted therapy, boasts diverse applications. Here are four key uses:

Antibody-Drug Conjugates (ADCs): A vital element in ADC synthesis, Fmoc-Val-Cit-PAB plays a crucial role in delivering cytotoxic drugs specifically to cancer cells. This linker guarantees drug inactivity in circulation, only activating within target cells. Such precision minimizes off-target effects and enhances the therapeutic index of anticancer medications.

Targeted Prodrug Activation: Leveraging Fmoc-Val-Cit-PAB facilitates the creation of prodrugs with selective activation in specific tissues or cells. Through linker attachment to a prodrug, researchers ensure active drug release triggered by specific enzymatic activity in diseased tissues. This innovative strategy elevates drug efficacy while reducing systemic toxicity.

Peptide Drug Conjugation: In the realm of peptide-based drug design, Fmoc-Val-Cit-PAB acts as a stable linker for coupling therapeutic peptides to drug molecules or delivery systems. This linker provides chemical stability, enabling controlled peptide release in targeted environments. Such applications are pivotal in advancing peptide therapeutics and drug delivery systems.

Bioconjugation Studies: Employed in bioconjugation investigations, Fmoc-Val-Cit-PAB facilitates linking diverse biomolecules like peptides, proteins, and antibodies to other functional entities. Its use guarantees a stable and controlled connection between biomolecules and conjugated substances, fostering the creation of multifunctional bioconjugates for diagnostics, therapeutics, and research pursuits.